Patient No. | Diagnosis | T2 | FA Mean | ADC |
---|---|---|---|---|
1 | MS | C2* | 0.48 | 1.52 |
C3 | 0.81 | 1.3 | ||
C5* | 0.52 | 0.89 | ||
C7 | 0.79 | 0.8 | ||
D4* | 0.69 | 1.08 | ||
D7* | 0.66 | 1 | ||
2 | MS | C2 | 0.5 | 0.7 |
C3 | 0.67 | 0.92 | ||
3 | Sarcoidosis | C7 | 0.56 | 0.76 |
D7* | 0.67 | 0.84 | ||
4 | MS | C6* | 0.68 | 1.04 |
D5* | 0.57 | 1.17 | ||
5 | MS | D1 | 0.51 | 0.63 |
D4* | 0.56 | 1.08 | ||
D6 | 0.58 | 1.43 | ||
6 | MS | C7 | 0.62 | 1.02 |
D7* | 0.5 | 1 | ||
7 | PRN | C5 | 0.68 | 0.92 |
C7 | 0.65 | 0.84 | ||
D3 | 0.83 | 0.817 | ||
D5 | 0.7 | 1.12 | ||
D7 | 0.58 | 0.962 | ||
8 | TM | D3–D5* | 0.66 | 1.18 |
9 | Sarcoidosis | C3 | 0.84 | 0.75 |
C5 | 0.71 | 0.979 | ||
C7 | 0.74 | 0.878 | ||
D5 | 0.43 | 1.07 | ||
D7* | 0.65 | 0.87 | ||
D9 | 0.52 | 0.77 | ||
10 | TM | D3* | 0.6 | 0.9 |
11 | MS | C4 | 0.84 | 1.12 |
C6 | 0.5 | 1.024 | ||
D1 | 0.83 | 0.819 | ||
D4 | 0.87 | 1.001 | ||
D6* | 0.68 | 1.107 | ||
D8 | 0.83 | 1.106 | ||
12 | MS | D5* | 0.58 | 1.3 |
13 | MS | C3 | 0.5 | 0.8 |
C5 | 0.63 | 0.85 | ||
D7 | 0.74 | 0.843 | ||
D8 | 0.84 | 0.861 | ||
D10 | 0.86 | 0.937 | ||
14 | Sarcoidosis | D8* | 0.33 | 1.73 |
D9* | 0.32 | 2.32 | ||
15 | MS | D1 | 0.66 | 1.13 |
D2 | 0.74 | 1 |
Note:—FA indicates fractional anisotropy; ADC, apparent diffusion coefficient; MS, multiple sclerosis; TM, transverse myelitis; PRN, polyradiculoneuritis.
* Pathologic level seen on T2-weighted imaging.